Archive/Extract of Origanum vulgare L.: Chemical Composition by HPLC-DAD, Antioxidant Activity, Biocompatibility, and Antifungal and Antibiofilm Action
Extract of Origanum vulgare L.: Chemical Composition by HPLC-DAD, Antioxidant Activity, Biocompatibility, and Antifungal and Antibiofilm Action
Geovani Moreira da Cruz, Raquel Teles de Menezes, Lara Steffany de Carvalho et al.
July 11, 2026
en

Abstract

Candida spp. can cause systemic infections with high mortality in immunocompromised patients. Phytotherapy may be an alternative for adjunctive treatment of fungal infections. This study evaluated the phytochemical profile, cytotoxicity, genotoxicity, and antibiofilm activity of the hydroalcoholic extract of Origanum vulgare L. against Candida albicans, Candida tropicalis, and Candida dubliniensis. The extraction and quantification (flavonoids and phenols) were performed, and its antioxidant activity (DPPH) and the presence of bio-active compounds were investigated using high-performance liquid chromatography with Diode Array Detection (HPLC-DAD). Cytotoxicity and genotoxicity tests were conducted using HaCat cell lines. Antifungal activity on planktonic cultures was evaluated using the standard (CLSI M27-S4). The analysis of the extract on biofilms was verified with different exposure times. The extract demonstrated the presence of bioactive molecules, and antioxidant activity. The cytotoxicity test showed viability >70%. Genotoxicity revealed the presence of a few micronuclei in some dilutions. The Minimum Fungicidal Concentration was obtained for C. albicans and C. tropicalis. In the biofilm analysis, there was a reduction of more than 60% in all Candida spp. species at the 24 h exposure time. The findings suggest that the O. vulgare extract exhibits activity against Candida spp. and shows biocompatibility in human keratinocytes.

IPC Classification

A61C07

Keywords

extractoriganumvulgarechemicalcompositionhplc-dadantioxidantactivitybiocompatibilityantifungalantibiofilmactionanalyticacandidacausesystemicinfectionshighmortalityimmunocompromisedpatientsphytotherapyalternativeadjunctive
Reference this publication

€ 4.00